Inhibition of Dipeptidyl Peptidase-4 (DPP-4): A Target to Treat Type 2 Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 1875-6662|7|4|205-217

ISSN： 1573-4080

Source： Current Enzyme Inhibition, Vol.7, Iss.4, 2011-12, pp. : 205-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Dipeptidyl Peptidase-4 (DPP-4) - A Novel Approach to Treat Type 2 Diabetes

By  

Current Enzyme Inhibition, Vol. 1, Iss. 1, 2005-01 ,pp. : 65-73

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling Interaction Between Enzyme Diabetes Type 2 Dipeptidyl- Peptidase (DPP-4) and Main Compound of Cinnamon

By  

Current Enzyme Inhibition, Vol. 14, Iss. 1, 2018-03 ,pp. : 61-66

Bentham Science Publishers

Access to resources Recommend Favorite

Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective

By Deacon C.F.   Holst J.J.  

Biochemical and Biophysical Research Communications, Vol. 294, Iss. 1, 2002-05 ,pp. : 1-4

Elsevier

Access to resources Recommend Favorite

Rebuttal to Deacon and Holst: “Metformin effects on dipeptidyl peptidase IV degradation of glucagon-like peptide-1” versus “Dipeptidyl peptidase inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective”

By Demuth H-U.   Hinke S.A.   Pederson R.A.   McIntosh C.H.S.  

Biochemical and Biophysical Research Communications, Vol. 296, Iss. 2, 2002-08 ,pp. : 229-232

Elsevier

Access to resources Recommend Favorite

Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine

By Al-masri Ihab M.   Mohammad Mohammad K.   Tahaa Mutasem O.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 5, 2009-10 ,pp. : 1061-1066

Informa Healthcare

Access to resources Recommend Favorite